• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

谷草转氨酶活性对草酸钙成核和晶体生长的影响测定

Determination of GOT activity on nucleation and crystal growth of calcium oxalate.

作者信息

Azoury R, Sarig S, Garti N, Perlberg S, Randolph A D, Drach G W

出版信息

Urol Res. 1984;12(4):223-6. doi: 10.1007/BF00256808.

DOI:10.1007/BF00256808
PMID:6149642
Abstract

Crystal Size Distribution (CSD) and the yield of Calcium Oxalate Crystals in solutions with an admixture of 5 normal and 3 stone forming urines, were determined. A positive correlation was found between the median size, the number of particles and the overall inhibitory potentials of the urines toward calcium oxalate precipitation in vitro as reflected by Discriminating Index (DI) measurements. Incubation of two samples of stone formers' (SF) urines with glutamic-oxalacetic-transaminase (GOT) caused a reduction of aspartic acid concentration, an increase in glutamic acid concentration and a parallel decrease in the DI values. After 90 min of SF urine incubation with GOT the DI in three samples was improved and both the median size and number of particles reduced, by 28% and 45% respectively. These results could indicate that GOT activity changes the inhibitory power of the SF urine by transforming aspartic acid into glutamic acid, having thus most probably a part in the inhibition of CaOx stone formation.

摘要

测定了含有5份正常尿液和3份结石形成尿液混合物的溶液中草酸钙晶体的晶体尺寸分布(CSD)和产率。通过鉴别指数(DI)测量发现,尿液的中位尺寸、颗粒数量与尿液对草酸钙沉淀的总体抑制潜力之间存在正相关。将两份结石形成者(SF)的尿液样本与谷草转氨酶(GOT)一起孵育,导致天冬氨酸浓度降低、谷氨酸浓度升高,同时DI值平行下降。在SF尿液与GOT孵育90分钟后,三个样本中的DI得到改善,中位尺寸和颗粒数量分别减少了28%和45%。这些结果可能表明,GOT活性通过将天冬氨酸转化为谷氨酸来改变SF尿液的抑制能力,因此很可能在抑制草酸钙结石形成中起作用。

相似文献

1
Determination of GOT activity on nucleation and crystal growth of calcium oxalate.谷草转氨酶活性对草酸钙成核和晶体生长的影响测定
Urol Res. 1984;12(4):223-6. doi: 10.1007/BF00256808.
2
Retardation of calcium oxalate precipitation by glutamic-oxalacetic-transaminase activity.
Urol Res. 1982;10(4):169-72. doi: 10.1007/BF00255939.
3
Biological control to diminish dangers of urolithiasis.
Urol Int. 1985;40(5):274-6. doi: 10.1159/000281098.
4
Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls.尿大分子对特发性结石形成者和健康对照者草酸钙成核的影响。
Clin Chim Acta. 1995 Jul 31;239(1):1-11. doi: 10.1016/0009-8981(95)06092-r.
5
May enzyme activity in urine play a role in kidney stone formation?
Urol Res. 1982;10(4):185-9. doi: 10.1007/BF00255942.
6
Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.正常人及特发性草酸钙结石患者中过饱和度与草酸钙结晶的关系。
Kidney Int. 1999 Mar;55(3):1041-50. doi: 10.1046/j.1523-1755.1999.0550031041.x.
7
Inhibitory effect of glutamic acid and aspartic acid on calcium oxalate crystal formation.
Eur Urol. 1990;17(2):173-7. doi: 10.1159/000464028.
8
Inhibitory activity of whole urine: a comparison of urines from stone formers and healthy subjects.全尿的抑制活性:结石形成者与健康受试者尿液的比较。
Clin Chim Acta. 1986 Jan 15;154(1):59-67. doi: 10.1016/0009-8981(86)90088-4.
9
Crystal growth of calcium oxalate in urine of stone-formers and normal controls.草酸钙在结石形成者和正常对照者尿液中的晶体生长。
Urol Res. 1991;19(3):159-64. doi: 10.1007/BF00303742.
10
Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall's plugs and calcium oxalate crystalluria in a computer model of renal function.在肾脏功能计算机模型中,通过肾单位的肾小管液成分波动在兰德尔斑和草酸钙结晶尿形成起始过程中的潜在作用。
Urolithiasis. 2015 Jan;43 Suppl 1:93-107. doi: 10.1007/s00240-014-0737-1. Epub 2014 Nov 20.

本文引用的文献

1
Effects of urinary organic macromolecules on crystallization of calcium oxalate: enhancement of nucleation.尿中有机大分子对草酸钙结晶的影响:成核增强
J Urol. 1980 Apr;123(4):519-23. doi: 10.1016/s0022-5347(17)56001-2.
2
Retardation of calcium oxalate precipitation by glutamic-oxalacetic-transaminase activity.
Urol Res. 1982;10(4):169-72. doi: 10.1007/BF00255939.
3
Citrate in urine and serum and associated variables in subgroups of urolithiasis. Results from an outpatient stone clinic.
Nephron. 1982;31(3):194-202. doi: 10.1159/000182646.
4
Follow-up of drug therapy efficacy to prevent recurrence of calcium oxalate kidney stone formation.药物治疗预防草酸钙肾结石形成复发的疗效随访。
J Urol. 1983 Jun;129(6):1258-61. doi: 10.1016/s0022-5347(17)52671-3.
5
A method for discrimination between calcium oxalate kidney stone formers and normals.一种区分草酸钙肾结石患者与正常人的方法。
J Urol. 1982 Sep;128(3):645-9. doi: 10.1016/s0022-5347(17)53085-2.
6
May enzyme activity in urine play a role in kidney stone formation?
Urol Res. 1982;10(4):185-9. doi: 10.1007/BF00255942.
7
Calcium oxalate crystalluria and inhibitors of crystallization in recurrent renal stone-formers.复发性肾结石患者的草酸钙结晶尿症及结晶抑制剂
Clin Sci. 1972 Oct;43(4):499-506. doi: 10.1042/cs0430499.
8
Growth of calcium oxalate crystals. I. A model for urinary stone growth.草酸钙晶体的生长。I. 尿结石生长模型。
Invest Urol. 1975 Jul;13(1):31-5.
9
Calcium-containing renal stones.含钙肾结石
Kidney Int. 1978 May;13(5):383-9. doi: 10.1038/ki.1978.56.
10
Inhibition of calcium oxalate dihydrate crystallization by chemical modifiers: I. Pyrophosphate and methylene blue.
J Urol. 1978 Jan;119(1):99-103. doi: 10.1016/s0022-5347(17)57395-4.